Does choline-derived betaine remethylate homocysteine via BHMT when folate or B12 remethylation is limited?

The metabolic relationship between choline, betaine, and homocysteine is a well-established mechanism in human biochemistry, functioning as a critical secondary pathway for maintaining cellular methylation and amino acid balance.

Clinical and effectiveness evidence

• Homocysteine Reduction: Betaine-homocysteine S-methyltransferase (BHMT) is a primary regulator of plasma homocysteine. Clinical trials have demonstrated that oral betaine supplementation (doses ranging from 1.5 to 6 grams per day) can reduce homocysteine levels by 10% to 20% in healthy individuals and by up to 50% or more in those with hyperhomocysteinemia.
• Response to Nutrient Deficiency: In populations where folate or vitamin B12 levels are low—common in aging adults due to decreased absorption—the reliance on the BHMT pathway increases significantly. Studies using stable isotope tracers show that when the folate-dependent pathway is compromised, the body shifts its metabolic flux toward the choline-to-betaine pathway to prevent toxic homocysteine accumulation.
• Population Significance: Research indicates that for individuals with common genetic variations, such as the MTHFR C677T polymorphism, dietary choline and betaine become even more critical for maintaining methionine levels and genomic stability.

Mechanistic explanations

• Two-Step Oxidation: Choline is first transported into the mitochondria of liver and kidney cells. It is oxidized to betaine aldehyde by the enzyme choline dehydrogenase (CHDH), and then further oxidized to betaine by betaine aldehyde dehydrogenase (BADH).
• Methyl Transfer: The BHMT enzyme facilitates the direct transfer of a methyl group from betaine to homocysteine. This reaction produces methionine (the precursor for S-adenosylmethionine, the body's universal methyl donor) and dimethylglycine (DMG).
• Parallel Pathway System: While the methionine synthase (MS) pathway requires folate and B12 and occurs in most tissues, the BHMT pathway is predominantly active in the liver and kidneys. This localization allows these organs to act as a metabolic "buffer," clearing homocysteine that the rest of the body cannot process when B-vitamins are scarce.

Bottom line

The evidence strongly supports the claim: choline is oxidized to betaine, which then fuels an essential backup pathway for homocysteine remethylation via BHMT. This mechanism is vital for metabolic health, especially when folate and vitamin B12 levels are insufficient to support the primary remethylation cycle.